A new treatment regimen for rosacea: onabotulinumtoxinA.

摘要: Rosacea is a cutaneous condition with several clinical subtypes that are commonly seen in daily medical practice. There many different treatment modalities for each of the physical findings associated this disease, and all have varying results. As use onabotulinumtoxinA rises, its benefit growing number diseases increases. The authors report anecdotal evidence patients rosacea experiencing improved symptoms erythema flushing after intradermal, microdroplets onabotulinumtoxinA. were no adverse events reported any treatments. mechanism action through likely neurogenic component to vascular dysfunction, inflammation, hypersebaceous activity reviewed.